Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Journal: Radiation oncology (London, England)
PMID:

Abstract

INTRODUCTION: The delineation of organs-at-risk and lymph node areas is a crucial step in radiotherapy, but it is time-consuming and associated with substantial user-dependent variability in contouring. Artificial intelligence (AI) appears to be the solution to facilitate and standardize this work. The objective of this study is to compare eight available AI software programs in terms of technical aspects and accuracy for contouring organs-at-risk and lymph node areas with current international contouring recommendations.

Authors

  • Céline Meyer
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Sandrine Huger
    Medical Physics Department, Institut de Cancérologie de Lorraine - Alexis-Vautrin, Vandœuvre-Lès-Nancy, France.
  • Marie Bruand
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Thomas Leroy
    Radiation department, Clinique Les Dentelières, Valenciennes, France.
  • Jérémy Palisson
    Medical Physics Department, Centre de la Baie, Avranches, France.
  • Paul Rétif
    Medical Physics Department, CHR Metz-Thionville, Metz, France.
  • Thomas Sarrade
    Radiation Department, AP-HP, Hôpital Tenon, Paris, France.
  • Anaïs Barateau
    Univ Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, F-35000 Rennes, France.
  • Sophie Renard
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Maria Jolnerovski
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Nicolas Demogeot
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Johann Marcel
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Nicolas Martz
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Anaïs Stefani
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Selima Sellami
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Juliette Jacques
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Emma Agnoux
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • William Gehin
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Ida Trampetti
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Agathe Margulies
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Constance Golfier
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Yassir Khattabi
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Olivier Cravéreau
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Alizée Renan
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Jean-François Py
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France.
  • Jean-Christophe Faivre
    Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin CLCC - Unicancer, 6 avenue de Bourgogne - CS 30 519, 54 511, Vandoeuvre-Lès-Nancy Cedex, France. jc.faivre@nancy.unicancer.fr.